Cardiovascular Risk and Physical Activity Score in Type II Diabetic Patients: The Case of Laquintinie Hospital in Douala (Cameroon)

Keywords

Abstract

References

1. [1]REFERENCES
2. [2]1.Oranisation Mondiale de la Sante. Noncommunicable Diseases: Progress Monitor 2022. https://apps.who.int/iris/bitstream/handle/10665/353048/9789240047761-eng.pdf
3. [3]2.Ong K L, Stafford L K, McLaughlin S A, Boyko E J, Vollset S E, Smith A E, Dalton B E, Duprey J, Cruz J A, Hagins H, Lindstedt P A, Aali A, Abate Y H, Abate M D, Abbasian M, Abbasi-Kangevari Z, Abbasi-Kangevari M, ElHafeez S A, Abd-Rabu R Vos T. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet 2023; 402(10397) :203–234. https://doi.org/10.1016/S0140-6736(23)01301-6
4. [4]3.International Diabetes Federation. Diabetes Atlas. 2025.
5. [5]4.Bigna J J, Nansseu J R, Katte J C, Noubiap J J. Prevalence of prediabetes and diabetes mellitus among adults residing in Cameroon: A systematic review and meta-analysis. Diabetes Research and Clinical Practice 2018; 137: 109–118. https://doi.org/10.1016/j.diabres.2017.12.005
6. [6]5.Mbanya J-C, Motala AA, Sobngwi E, Assah F, and Enoru S. “Diabetes in sub-Saharan Africa,” The Lancet 2010; 375 (9733): 2254–2266.
7. [7]6.Jaffiol C. “The burden of diabetes in Africa: a major public health problem,” Bulletin de l'Académie Nationale de Médecine 2011; 195(6): 1239-1254.
8. [8]7.World Health Organization. Global Report on Diabetes. Isbn 2016; 978: 88. https://doi.org/ISBN 978 92 4 156525 7
9. [9] 8.Reid D, Brett G, Hamilton P, Keen H, Rose G. Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet 1974; 1: 469-73.
10. [10]9.Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131- 41.
11. [11]10.Ducimetiere P, Eschwege, Papoz L, Richard JL, Claude JR and Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 2012; 19: 205-10.
12. [12]11.DECODE (Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe) Study Group, Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The Lancet 1999; 354: 617-21.
13. [13]12.Stamler J, Vaccaro O, Neaton J, Wentworth D: Diabetes, other riskfactors, and12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16(2):434-44. doi: 10.2337/diacare.16.2.434.
14. [14]13.Church T S , ChengY J, Earnest PC, Barlow EC, GibbonsWL, Priest LE, Blair NS. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 2024; 27(1) :83-8. doi: 10.2337/diacare.27.1.83.
15. [15]14.Mayer-Davis E, D’Agostino R, Karter A, Haffner S, Rewers M, Saad M, Bergman R. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Journal of American Medical Association 1998; 279: 669–674.
16. [16]15.Wannamethee S, Shaper A, Alberti K. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Archives Internal Medicine 2000; 160: 2108–2116.
17. [17]16.Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA: Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002; 25: 1612–1618.
18. [18]17.Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001; 344: 1343–1350.
19. [19]18.Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal Medicine 2002; 346: 393-403.
20. [20]19.Hu G, Qiao Q, Silventoinen K, Eriksson JG, Jousilahti P, Lindstrom J, Valle TT, Nissinen A, Tuomilehto J. Occupational, commuting, and leisure-time physicalactivity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 2003; 46: 322-329.
21. [21]20.Hu G, Lindstrom J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J. Physicalactivity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Archives Internal Medicine 2004 ; 164 :892-896.
22. [22]21.Le Figaro. Exploration d’anomalie lipidique.LE FIGARO.fr Santé 2022 ; consulté le 07/22/2022 à 21hr56. Disponible à l’URL https://sante.lefigaro.fr/sante/analyse/exploirationdanomalie-lipidique/quels-sont-resultats.
23. [23]22.Craig CL, Marshall M, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngv A, Sallis JF, Oja P. Questionnaire international sur l’activité physique : fiabilité et validité dans 12 pays. Medicine.Science. Exercice sportif 2003 ; 35 : 1381-1395.
24. [24]23.Genest J, McPherson R, Jiri F, Todd A, Norm C, Carpentier A, Couture P, Dufour R, Fodor G, Gordon A F, Grover S, Gupta M, Hegele R A, Lau D C, Leiter L, Gary F L, E, Mancini J G B, Ng D, Glen J P, Sniderman A, Stone J A, Ehud U. Lignes directrices canadiennes 2009 de la Société canadienne de cardiologie pour le diagnostic et le traitement de la dyslipidémie et pour la prévention des maladies cardiovasculaires chez l’adulte. Journal Canadien de cardiologie 2009 ;25(10) :567-579.
25. [25] 24.D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117 (6): 743-53.
26. [26]25.Konaté M, Mariko S, Toure M, Traoré D, Sow DS, Ganame Y, Ouologuem N, Sidibé S, Bâ HO, Sangaré I, Sanou M, Mariko M, Coulibaly S, Menta I. Profil de Risque Cardiovasculaire des Sujets Diabétiques de Type 2 Hospitalisés à l’Hôpital du Mali. Health Sciences Disease 2022; 23 (4): 82-85.
27. [27] 26.Sow, D. S., Konaté, M., Traoré, D., Bah, M., Guindo, I., Mariko, M., Koné, A., & Sidibe, A. Hypertension Artérielle chez les Patients Diabétiques de Type 2 au Centre de Santé de Référence de la Commune I du District de Bamako. Health Science Disease 2020 ; 21(5) : 84 8.
28. [28] 27.Organisation Mondiale de la Santé 2022. Rapport sur la Santé dans le Monde 2002 - Réduire les risques et promouvoir.
29. [29] 28.Kraus W, Houmard J, Duscha B, Knetzger K, Wharton M, McCartney J, Bales C, Henes S, Samsa G, Otvos J, Kulkarni K, and Slentz C. Effects of the amount and intensity of exercise on plasma lipoproteins. New England Journal of Medicine 2002; 347: 1483–1492.
30. [30]29.Bassuk, Shari S, and JoAnn E Manson. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. Journal of Applied Physiology 2005; 99: 1193–1204, doi:10.1152/japplphysiol.00160.
31. [31] 30.Anspaugh D, Hunter S, Dignan M. Risk factors for cardiovascular disease among exercising and non-exercising women. American Journal Health Promotion 1996; 103: 171–4.
32. [32]31.Rothenbacher D, Koenig W, Brenner H. Lifetime physical activity patterns and risk of coronary heart disease. Heart 2006; 92: 1319–20.
33. [33]32.American Heart Association Heart Disease & Stroke Statistics (2011) Update. Retrieved February 8, Available at: http://circ.ahajournals.org/cgi/reprint/123/4/e18 consulté le 18 Mai 2023.

Authors (6)